PharmAccess is a group of non-profit organizations dedicated to improving access to quality healthcare in Africa. PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
This integrated approach is made possible by the following organizations:
For the fourth time, Medical Credit Fund has been selected for the ImpactAssets 50 (IA 50), an online database that connects investors to fund managers that deliver social, environmental and financial returns.
ImpactAssets released its seventh annual ImpactAssets 50 today, and for the fourth time since IA 50’s existence, Medical Credit Fund has been selected. IA 50 is the first publically available, online database of private debt and equity impact investment fund managers. It includes a range of funds across the globe, spanning diverse issue areas and investment, with demonstrated and compelling social and environmental impact. IA 50 serves as a gateway into the world of impact investing, offering an easy way to identify experienced impact investment firms.
“The IA 50 has become the go-to database for insights and actionable data on innovative managers creating impact with investment capital, which is especially valuable for family offices and accredited investors getting started in the impact space,” said Stephanie Cohn Rupp, Managing Director, and Partner at Tiedemann Wealth Management.
This year’s IA 50 included an estimated $29.2 billion in assets devoted to creating measurable, positive impact – nearly double the assets managed by IA 50 managers in the previous year. The seventh showcase includes larger funds, deep experience and diverse management. The 50 firms that have been selected demonstrate a wide range of impact investing activities across geographies, sectors and asset classes.
Take a look at Medical Credit Fund’s showcase!
